
Please try another search
Jiangsu Gdk Biological Technology Co., Ltd engages in the scientific research, production of human vaccines. The company offers quadrivalent influenza virus split vaccines. Its product pipeline has coverage for the prevention of principal infectious diseases, including influenza, rabies, chickenpox, herpes zoster, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.
Name | Age | Since | Title |
---|---|---|---|
Shenqian Nie | 76 | - | Director |
Liangbin Zhang | 49 | - | Director |
Jun Yu | 55 | 2024 | Chairman & Secretary of the Board |
Jianguo Xia | 51 | - | Deputy GM & Director |
Dachang Wei | 56 | - | Chairman of the Supervisory Board |
Rong Shao | 62 | - | Independent Director |
Ling Huang | 58 | - | Supervisor |
Huisheng Yu | 28 | - | Employee Supervisor |
Jianqiang Guan | 66 | - | Independent Director |
Hongxing Sun | 58 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review